Table 3 Management, resection margin, and recurrence status after hepatectomy
| Â | Centrally located | Peripherally located | P values |
|---|---|---|---|
( n = 24) | ( n = 135) | ||
Neoadjuvant chemotherapy | 4 (16.7%) | 11 (8.1%) | 0.247 |
 Effective (stable, partial/complete response | 0 (0.0%) | 4 (36.4%) | 0.159 |
 Progression | 4 (100%) | 7 (63.6%) |  |
Anatomic resectiona | 7 (29.2%) | 25 (18.5%) | 0.269 |
Resection margin (mm) | |||
 Involved | 10 (41.7%) | 20 (14.8%) | 0.003 |
 <10 mm | 13 (54.2%) | 85 (63.0%) |  |
 ≥10 mm | 1 (4.2%) | 30 (22.2%) |  |
Recurrence after hepatectomy | 22 (91.7%) | 100 (74.1%) | 0.045 |
 Confined in the liver, lung, or both | 7 (31.8%) | 31 (31.0%) | 1.000 |
 Recurrence in other distant organ(s) | 15 (68.2%) | 69 (69.0%) |  |
Early recurrenceb | 9 (37.5%) | 24 (17.8%) | 0.032 |
Repeated hepatectomy | 1 (4.2%) | 13 (9.6%) | 0.696 |